ELABS — Elliptic Laboratories ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK312.67m
- NOK282.72m
- NOK101.31m
Annual cashflow statement for Elliptic Laboratories ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | NAS | NAS | NAS | NAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.1 | -39.3 | -47 | 17 | -58.2 |
| Depreciation | |||||
| Non-Cash Items | 11 | 9.37 | 9.4 | 2.09 | 8.53 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -17 | 1.27 | -16.7 | -51.6 | 30.4 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -10.8 | -17.3 | -38.1 | -10.6 | 5.99 |
| Capital Expenditures | -17.6 | -23.3 | -25.6 | -30.5 | -29.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 2.24 | 0.896 | 5.95 | 2.23 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -17.6 | -21.1 | -24.7 | -24.6 | -26.9 |
| Financing Cash Flow Items | -9.19 | 1.97 | -1.95 | -1.83 | -1.54 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 147 | -2.26 | -1.46 | -7.13 | -10.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 118 | -39.9 | -62.6 | -39.2 | -33.3 |